The Sunrise Post

Starting dual-action incretin therapy marks the beginning of a significant health journey for you. If your doctor has prescribed medications like mounjaro for weight loss , you're probably wondering what changes to expect in the coming weeks. This treatment works by mimicking hormones that regulate blood sugar and appetite, helping you feel fuller longer and potentially leading to substantial weight loss. Your body will respond uniquely to this therapy, but most people experience predictable patterns of changes. Let's explore what you might encounter during the first crucial three months. Week 1-2: The Adjustment Phase During your first two weeks, your body begins adjusting to the medication. You'll likely start on a lower dose to help your system adapt gradually. What you might experience: Mild nausea that typically comes and goes Reduced hunger even with smaller portions Slight fatigue as your body adjusts Early changes in blood sugar levels if you have diabetes Many ...

Knowing potential plateaus are ahead helps set yourself up mentally while establishing healthy habits for the long haul. The newly approved Type 2 diabetes medication Mounjaro for weight loss (tirzepatide) has shown promising weight loss results in clinical trials. However, as many discover upon starting treatment, seeing the numbers rapidly drop on the scale those first few weeks eventually gives way to slow, plateaued progress. Understanding this is an inevitable part of the journey prevents frustration and sustains the commitment to positive lifestyle changes driving success. This guide reviews why plateaus happen, realistic milestones that typically emerge for patients also receiving nutritional and activity counseling, and most importantly, sustainable evidence-based strategies to support your overall wellness aims if progress stalls. Why Metabolic Adaptation Causes Weight Loss to Slow? In Mounjaro trials, average participants lost up to 22.5% of starting body weight over 15 mont...